Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance

BACKGROUND: Extent of myocardial fibrosis (MF) determined using late gadolinium enhanced (LGE) predicts outcomes, but gadolinium is contraindicated in advanced renal disease. We assessed the ability of native T1-mapping to identify and quantify MF in aortic stenosis patients (AS) as a model for use...

Descripción completa

Detalles Bibliográficos
Autores principales: Graham-Brown, M. P., Singh, A. S., Gulsin, G. S., Levelt, E., Arnold, J. A., Stensel, D. J., Burton, J. O., McCann, G. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044074/
https://www.ncbi.nlm.nih.gov/pubmed/30005636
http://dx.doi.org/10.1186/s12872-018-0885-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044074/
https://www.ncbi.nlm.nih.gov/pubmed/30005636
http://dx.doi.org/10.1186/s12872-018-0885-2

Ejemplares similares